Redpoint Oncology, Inc.

Holden, MA

UEI
SHDKHFGJNHT4
CAGE
9U0Y9
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Woman Owned Business
  • Woman Owned Small Business
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
83 Parker Ave, Holden, MA 01520, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Grant subawards

Prime recipient Prime award Amount Awarded
Center For The Advancement Of Science In Space, Inc. Evaluating the Efficacy of Novel Antibody-Drug Conjugates (ADCs) for Therapy-Resistant Cancers in Accelerated Disease Models 80JSC018M0005 $259,800

Quick answers

Is Redpoint Oncology, Inc. registered in SAM.gov?

Yes. Redpoint Oncology, Inc.'s SAM.gov registration is active through September 10, 2027.

What is Redpoint Oncology, Inc.'s CAGE code?

Redpoint Oncology, Inc.'s CAGE code is 9U0Y9, and its Unique Entity ID (UEI) is SHDKHFGJNHT4.

What is Redpoint Oncology, Inc.'s most recent federal award?

Redpoint Oncology, Inc.'s most recent federal grant award is Sbir phase I: developing next-generation payloads for targeted therapies (2506212), from National Science Foundation, on June 1, 2025.

On GovTribe

See Redpoint Oncology, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe